Clinical Trials

Study Title:
A Phase 1/2 Dose Escalation and Dose Expansion Study of BA3021 Alone and in Combination With Nivolumab In Patients With Advanced Solid Tumors

For more information about the trial above please contact the study team:

Principal Investigator, Mariam Alexander, at alexanma@musc.edu.

Study Coordinator, Megan Buss, at bussm@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina